High-dose therapy and growth factor mobilized peripheral blood progenitor cell support for responding patients with metastatic breast cancer.
Stadtmauer
E A
EA
Bone Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia.
Hodi
F S
FS
Sickles
C
C
Biggs
D D
DD
Mangan
P
P
Buzby
G
G
Zaleta
E
E
Silberstein
L
L
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001773:Blood Cells / Q000166:cytology / Q000187:drug effects; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000556:secondary / Q000628:therapy*; D016190:Carboplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology; D006410:Hematopoiesis; D016298:Hematopoietic Cell Growth Factors / Q000494:pharmacology; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D013852:Thiotepa / Q000008:administration & dosage; D013997:Time Factors; D014182:Transplantation, Autologous
D016298:Hematopoietic Cell Growth Factors; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D003520:Cyclophosphamide; D013852:Thiotepa; D016190:Carboplatin